Literature DB >> 1975270

Do neuroleptic drugs still have a place in neurological therapy?

T Klockgether1, J Dichgans.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1975270     DOI： 10.1007/bf00314622

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  34 in total

1.  [The treatment of zona and of its associated pains. Study of the results obtained with levomepromazine].

Authors:  J SIGWALD; D BOUTTIER; F CAILLE
Journal:  Therapie       Date:  1959       Impact factor: 2.070

2.  Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.

Authors:  H Pakkenberg; R Fog
Journal:  Arch Neurol       Date:  1974-11

3.  Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.

Authors:  N E Andén; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1971-07       Impact factor: 4.432

4.  Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.

Authors:  E Scholz; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

5.  An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies.

Authors:  H D Langohr; M Stöhr; F Petruch
Journal:  Eur Neurol       Date:  1982       Impact factor: 1.710

6.  Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.

Authors:  E G Spokes
Journal:  Brain       Date:  1980-03       Impact factor: 13.501

Review 7.  Acute dystonia induced by neuroleptic drugs.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study.

Authors:  Francisco J Gomez-Perez; Juan A Rull; Haroldo Dies; Guillermo J Rodriguez-Rivera; Jorge Gonzalez-Barranco; Oscar Lozano-Castañeda
Journal:  Pain       Date:  1985-12       Impact factor: 6.961

9.  Tetrabenazine and movement disorders.

Authors:  S W Asher; M J Aminoff
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

10.  Agranulocytosis during treatment with chlozapine.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I P Palva
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953
View more
  1 in total

1.  Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

Authors:  J P van Vugt; S Siesling; M Vergeer; E A van der Velde; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.